BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8100692)

  • 1. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Wilcosky TC; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Osmond D; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1993 Aug; 119(3):185-93. PubMed ID: 8100692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM; Nelson KE; Solomon L; Bonds M; Rizzo RT; Scavotto J; Astemborski J; Vlahov D
    JAMA; 1992 Jan; 267(3):369-73. PubMed ID: 1727959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).
    Anastos K; Kalish LA; Palacio H; Benson CA; Delapenha R; Chirgwin K; Stonis L; Telzak EE
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):141-7. PubMed ID: 10360806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group.
    Markowitz N; Hansen NI; Hopewell PC; Glassroth J; Kvale PA; Mangura BT; Wilcosky TC; Wallace JM; Rosen MJ; Reichman LB
    Ann Intern Med; 1997 Jan; 126(2):123-32. PubMed ID: 9005746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
    Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
    JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ; Aldamiz-Etxebarria M; Agud JM; Arévalo JM; Almaraz MJ; Ayensa C
    Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
    Janis EM; Allen DW; Glesby MJ; Carey LA; Mundy LM; Gopalan R; Chaisson RE
    Am J Med; 1996 Feb; 100(2):186-92. PubMed ID: 8629653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
    Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
    Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):93-8. PubMed ID: 9893191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk for developing tuberculosis among anergic patients infected with HIV.
    Moreno S; Baraia-Etxaburu J; Bouza E; Parras F; Pérez-Tascón M; Miralles P; Vicente T; Alberdi JC; Cosín J; López-Gay D
    Ann Intern Med; 1993 Aug; 119(3):194-8. PubMed ID: 8100693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group.
    Klein RS; Sobel J; Flanigan T; Smith D; Margolick JB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):238-44. PubMed ID: 10077171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE; Schein MF; Hall CA; Barnes SA
    Clin Infect Dis; 1994 Jul; 19(1):26-32. PubMed ID: 7948554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association of induration size with HIV infection among drug users reacting to tuberculin.
    Gourevitch MN; Hartel D; Schoenbaum EE; Klein RS
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1029-33. PubMed ID: 8887602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel.
    García-García ML; Valdespino-Gómez JL; García-Sancho C; Mayar-Maya ME; Palacios-Martínez M; Balandrano-Campos S; Escobar-Gutiérrez A; Peruga A; Weissenbacher M; Daniels E
    Int J Epidemiol; 2000 Apr; 29(2):369-75. PubMed ID: 10817138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
    Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
    N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.
    Blatt SP; Hendrix CW; Butzin CA; Freeman TM; Ward WW; Hensley RE; Melcher GP; Donovan DJ; Boswell RN
    Ann Intern Med; 1993 Aug; 119(3):177-84. PubMed ID: 8100691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection.
    Villarino ME; Geiter LJ; Schulte JM; Castro KG
    AIDS; 1994 Apr; 8(4):477-81. PubMed ID: 8011250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.